Jeffrey R. Lilly
Partner
Experience
Jeffrey R. Lilly is a highly experienced litigator representing manufacturers, pharmaceutical companies, and other businesses in complex product liability and commercial litigation. For more than three decades, he has defended clients in state and federal courts across the United States, including in national multidistrict litigation and other high-stakes disputes. Jeff has extensive experience with pharmaceutical and medical device litigation and mass tort matters, and is particularly skilled in preparing and defending key witnesses and managing complex discovery. He is a trusted advisor to clients facing significant litigation exposure, helping them develop practical strategies for managing risk and resolving claims efficiently.
Jeff has represented Fortune 500 clients as well as smaller businesses, and has handled medical device and national mass drug defense work on national trial teams for international pharmaceutical companies. During his 30 years in practice, Jeff has been a strong advocate for clients facing professional liability, premises liability, and construction defect matters as well as a broad range of commercial disputes. He began his career as an Assistant Attorney General for the State of Texas, defending medical malpractice cases brought against individual physicians and state medical institutions.
Related Areas
Honors & Awards
Who’s Who Legal International
- Product Liability Defense Lawyers (2011-20)
Background
Admissions
- Texas
- Arkansas
- U.S. District Courts for the Eastern, Northern, Southern, and Western Districts of Texas
Education
- University of Miami School of Law, J.D., 1993
- The University of Texas at Austin, B.A., 1990
Certifications
- State of Texas Certified Mediator
Professional Affiliations
- Austin Bar Association
Community Involvement
- American Red Cross of Central and South Texas, Austin Chapter
- Board of Directors, Chair, 2026-current
- Board of Directors, 2022-current
- Austin Bar Foundation
- Board of Directors, 2022-current
- Anti-Defamation League
- Board of Directors, 2026-current
News & Knowledge
Publications & Events
- “Spoliation and the Long-Awaited Federal E-Discovery Rule Changes,” Inside Counsel, May 1, 2015
- “Action is Needed to Control Spoliation Creep,” Inside Counsel, April 1, 2015
- “The Growing Problem of Spoliation Sanctions,” Inside Counsel, Mar. 1, 2015
- “Proposed E-Discovery Amendments Are Only the First Step,” Texas Lawyer, Feb. 1, 2015
- “Fraud on the Market” chapter in “Navigating Drug and Medical Device Legal Issues: Leading Lawyers on Handling Trademark, Fraud, and Liability Concerns,” Inside the Minds, Jan. 1, 2014
- “Boost Profits with Training on Email Professionalism,” Texas Lawyer, April 15, 2013
- Why Corporate Defendants Should Embrace E-Discovery,” Executive Counsel Magazine, May 1, 2012
- “Defending Against E-Discovery Sanctions Begins Yesterday,” IADC Drug, Device and Biotechnology Committee Newsletter, June 1, 2011
RECENT INSIGHTS
September 28, 2026